Non-coding RNAs in disease: from mechanisms to therapeutics

被引:248
|
作者
Nemeth, Kinga [1 ]
Bayraktar, Recep [1 ]
Ferracin, Manuela [2 ,3 ]
Calin, George A. [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol Dept, Houston, TX 77030 USA
[2] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Bologna, Italy
[4] Univ Texas MD Anderson Canc Ctr, RNA Interference & Noncoding RNA Ctr, Houston, TX 77030 USA
关键词
CORONARY-ARTERY-DISEASE; CIRCULAR RNAS; PROGNOSTIC BIOMARKER; TRANSCRIPTION FACTOR; PROFILING REVEALS; PERIPHERAL-BLOOD; DOWN-REGULATION; POOR-PROGNOSIS; HEART-FAILURE; CELL-CYCLE;
D O I
10.1038/s41576-023-00662-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-coding RNAs (ncRNAs) are a heterogeneous group of transcripts that, by definition, are not translated into proteins. Since their discovery, ncRNAs have emerged as important regulators of multiple biological functions across a range of cell types and tissues, and their dysregulation has been implicated in disease. Notably, much research has focused on the link between microRNAs (miRNAs) and human cancers, although other ncRNAs, such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are also emerging as relevant contributors to human disease. In this Review, we summarize our current understanding of the roles of miRNAs, lncRNAs and circRNAs in cancer and other major human diseases, notably cardiovascular, neurological and infectious diseases. Further, we discuss the potential use of ncRNAs as biomarkers of disease and as therapeutic targets. In this Review, the authors describe our current knowledge of the role of microRNAs, long non-coding RNAs and circular RNAs in disease, with a focus on cardiovascular, neurological, infectious diseases and cancer. Further, they discuss the potential use of non-coding RNAs as disease biomarkers and as therapeutic targets.
引用
收藏
页码:211 / 232
页数:22
相关论文
共 50 条
  • [31] INSIGHTS INTO THE MECHANISMS OF NON-CODING RNAS' IMPLICATION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Khodayi-Shahrak, Majid
    Khalaj-Kondori, Mohammad
    Feizi, Mohammad Ali Hosseinpour
    Talebi, Mahnaz
    EXCLI JOURNAL, 2022, 21 : 921 - 940
  • [32] Novel molecular mechanisms of vascular disease: non-coding RNAs, inflammation, and radiation
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2019, 40 (30) : 2467 - 2470
  • [33] Non-coding RNAs in Alzheimer's Disease
    Tan, Lin
    Yu, Jin-Tai
    Hu, Nan
    Tan, Lan
    MOLECULAR NEUROBIOLOGY, 2013, 47 (01) : 382 - 393
  • [35] EMERGING EPIGENETIC MECHANISMS OF LONG NON-CODING RNAS
    Schaukowitch, K.
    Kim, T-K
    NEUROSCIENCE, 2014, 264 : 25 - 38
  • [36] Organellar non-coding RNAs: Emerging regulation mechanisms
    Dietrich, Andre
    Wallet, Clementine
    Iqbal, Rana Khalid
    Gualberto, Jose M.
    Lotfi, Frederique
    BIOCHIMIE, 2015, 117 : 48 - 62
  • [37] Long Non-Coding RNAs in Kidney Disease
    Ignarski, Michael
    Islam, Rashidul
    Mueller, Roman-Ulrich
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13):
  • [38] Molecular mechanisms of oncogenic long non-coding RNAs
    Shahandeh, A.
    BIOSCIENCE RESEARCH, 2013, 10 (01): : 38 - 54
  • [39] Long non-coding RNAs and human disease
    Harries, Lorna W.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 902 - 906
  • [40] Non-coding RNAs and Coronary Artery Disease
    Cardona-Monzonis, Alejandro
    Luis Garcia-Gimenez, Jose
    Mena-Molla, Salvador
    Pareja-Galeano, Helios
    de la Guia-Galipienso, Fernando
    Lippi, Giuseppe
    Pallardo, Federico V.
    Sanchis-Gomar, Fabian
    NON-CODING RNAS IN CARDIOVASCULAR DISEASES, 2020, 1229 : 273 - 285